Directori de persones
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grau: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publicacions

  • Silva, Elvio G.; Matias-Guiu, Xavier

    Clonality in gynecologic neoplasms: is it time to reevaluate clonality studies in gynecologic neoplasms? Is it possible to confirm multicentricity with clonality studies?

    ANNALS OF DIAGNOSTIC PATHOLOGY 16 312-314. .

    [doi:10.1016/j.anndiagpath.2012.01.007]

  • Llaurado, Marta; Ruiz, Anna; Majem, Blanca; Ertekin, Tugce; Colas, Eva; Pedrola, Nuria; Devis, Laura; Rigau, Marina; Sequeiros, Tamara; Montes, Melania; Garcia, Marta; Cabrera, Silvia; Gil-Moreno, Antonio; Xercavins, Jordi; Castellvi, Josep; Garcia, Angel; Ramon y Cajal, Santiago; Moreno, Gema; Alameda, Francesc; Vazquez-Levin, Monica; Palacios, Jose; Prat, Jaime; Doll, Andreas; Matias-Guiu, Xavier; Abal, Miguel; Reventos, Jaume

    Molecular bases of endometrial cancer: New roles for new actors in the diagnosis and the therapy of the disease

    MOLECULAR AND CELLULAR ENDOCRINOLOGY 358 244-255. .

    [doi:10.1016/j.mce.2011.10.003]

  • Castelblanco, Esmeralda; Gallel, Pilar; Ros, Susana; Gatius, Sonia; Valls, Joan; De-Cubas, Aguirre A.; Maliszewska, Agnieszka; Yebra-Pimentel, M. Teresa; Menarguez, Javier; Gamallo, Carlos; Opocher, Giuseppe; Robledo, Mercedes; Matias-Guiu, Xavier

    Thyroid paraganglioma. Report of 3 cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma, based on complementary DNA array results

    HUMAN PATHOLOGY 43 1103-1112. .

    [doi:10.1016/j.humpath.2011.08.022]

  • Vilardell, Felip; Novell, Anna; Martin, Javier; Santacana, Maria; Velasco, Ana; Diez-Castro, M. J.; Cuevas, Dolors; Jose Panades, M.; Gonzalez, Serafin; Llombart, Antonio; Iglesias, Edelmiro; Matias-Guiu, Xavier

    Importance of assessing CK19 immunostaining in core biopsies in patients subjected to sentinel node study by OSNA

    VIRCHOWS ARCHIV 460 569-575. .

    [doi:10.1007/s00428-012-1241-z]

  • Montserrat, Nuria; Mozos, Ana; Llobet, David; Dolcet, Xavier; Pons, Cristina; Garcia de Herreros, Antonio; Matias-Guiu, Xavier; Prat, Jaime

    Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma

    HUMAN PATHOLOGY 43 632-643. .

    [doi:10.1016/j.humpath.2011.06.021]

  • Eritja, Nuria; Mirantes, Cristina; Llobet, David; Masip, Gemma; Matias-Guiu, Xavier; Dolcet, Xavi

    ER alpha-mediated repression of pro-inflammatory cytokine expression by glucocorticoids reveals a crucial role for TNF alpha and IL1 alpha in lumen formation and maintenance

    JOURNAL OF CELL SCIENCE 125 1929-1944. .

    [doi:10.1242/jcs.095067]

  • Llaurado, Marta; Abal, Miguel; Castellvi, Josep; Cabrera, Silvia; Gil-Moreno, Antonio; Perez-Benavente, Asumpcio; Colas, Eva; Doll, Andreas; Dolcet, Xavier; Matias-Guiu, Xavier; Vazquez-Levin, Monica; Reventos, Jaume; Ruiz, Anna

    ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells

    INTERNATIONAL JOURNAL OF CANCER 130 1532-1543. .

    [doi:10.1002/ijc.26148]

  • Das, A.; Pushparaj, C.; Bahi, N.; Sorolla, A.; Herreros, J.; Pamplona, R.; Vilella, R.; Matias-Guiu, X.; Marti, R. M.; Canti, C.

    Functional expression of voltage-gated calcium channels in human melanoma

    PIGMENT CELL & MELANOMA RESEARCH 25 200-212. .

    [doi:10.1111/j.1755-148X.2012.00978.x]

  • Yeramian, Andree; Sorolla, Anabel; Velasco, Ana; Santacana, Maria; Dolcet, Xavier; Valls, Joan; Abal, Leandre; Moreno, Sara; Egido, Ramon; Casanova, Josep M.; Puig, Susana; Vilella, Ramon; Llombart-Cussac, Antonio; Matias-Guiu, Xavier; Marti, Rosa M.

    Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway

    INTERNATIONAL JOURNAL OF CANCER 130 967-978. .

    [doi:10.1002/ijc.26096]

  • Santacana, Maria; Yeramian, Andree; Velasco, Ana; Bergada, Laura; Gatius, Sonia; Garcia, Virginia; Azueta, Ainara; Palacios, Jose; Dolcet, Xavier; Oliva, Esther; Matias-Guiu, Xavier

    Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: role for proteins involved in resistance to apoptosis and hypoxia

    Histopathology 60 460-471. .

    [doi:10.1111/j.1365-2559.2011.04106.x]

  • Pallares, J; Bergada, L; Santacana, M; Dolcet, X; Valls, J; Dusso, A; Matias-Guiu, X

    Downregulation of CYP27A1 Expression and Activity in Human Endometrial Carcinoma Implicates an Abnormal Bioactivation of Vitamin D in Advanced Endometrial Carcinogenesis

    Modern Pathology 25 291-291. .

  • Vilanova-Pàmies C; López-Agulló S; Matias-Guiu X; León-Vallés M; Tarragona-Foradada J; Prados-Chica JJ

    Malaria cerebral fulminante con parada cardiaca extrahospitalaria.

    REVISTA CLINICA ESPANOLA 211 -. .

    [doi:10.1016/j.rce.2011.05.007]

Projectes

  • Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU